Trinity Biotech (TRIB) Non Operating Interest Expenses (2009 - 2010)
Trinity Biotech (TRIB) posted quarterly Non Operating Interest Expenses of -$231000.0 for Q1 2010, up 19.79% year-on-year from -$192834.8 in Q1 2009, and up 10.81% on a QoQ basis from -$259000.0 in Q4 2009.
Trinity Biotech (TRIB) Non Operating Interest Expenses (2009 - 2010) Analysis & Trends
Trinity Biotech (TRIB) has reported Non Operating Interest Expenses for 2 consecutive years, with -$231000.0 the latest figure, recorded in Q1 2010.
- Quarterly Non Operating Interest Expenses rose 19.79% year-over-year to -$231000.0 in Q1 2010, while the trailing twelve-month figure through Mar 2010 was -$1.1 million (up 34.36% YoY) and the FY2013 annual result came in at $1.2 million, down 44.11% from the prior year.
- Non Operating Interest Expenses advanced to -$231000.0 in Q1 2010 per TRIB's latest filing, from -$259000.0 in the prior quarter.
- Over the last five years, Non Operating Interest Expenses for TRIB reached as high as -$231000.0 in Q1 2010 and fell as low as -$348000.0 in Q2 2009.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non Operating Interest Expenses (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn | - |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn | - |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn | - |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn | - |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn | - |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn | - |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn | - |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn | - |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - | - |
| 10 | Trinity Biotech | 93,750.00 | -5.04 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2010 | -231,000.00 |
| Dec 31, 2009 | -259,000.00 |
| Sep 30, 2009 | -289,000.00 |
| Jun 30, 2009 | -348,000.00 |
| Mar 31, 2009 | -288,000.00 |